127 related articles for article (PubMed ID: 19176033)
21. The mouse chemerin receptor gene, mcmklr1, utilizes alternative promoters for transcription and is regulated by all-trans retinoic acid.
Mårtensson UE; Bristulf J; Owman C; Olde B
Gene; 2005 Apr; 350(1):65-77. PubMed ID: 15792532
[TBL] [Abstract][Full Text] [Related]
22. Poly(ADP-ribose) polymerase upregulates E2F-1 promoter activity and DNA pol alpha expression during early S phase.
Simbulan-Rosenthal CM; Rosenthal DS; Luo R; Smulson ME
Oncogene; 1999 Sep; 18(36):5015-23. PubMed ID: 10490838
[TBL] [Abstract][Full Text] [Related]
23. Interferon-gamma regulation of the human mimecan promoter.
Tasheva ES; Conrad GW
Mol Vis; 2003 Jun; 9():277-87. PubMed ID: 12835654
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional regulation of human fibroblast growth factor receptor 1 by E2F-1.
Kanai M; Tashiro E; Maruki H; Minato Y; Imoto M
Gene; 2009 Jun; 438(1-2):49-56. PubMed ID: 19303924
[TBL] [Abstract][Full Text] [Related]
25. 8-Chloro-adenosine-induced E2F1 promotes p14ARF gene activation in H1299 cells through displacing Sp1 from multiple overlapping E2F1/Sp1 sites.
Zhang HJ; Li WJ; Yang SY; Li SY; Ni JH; Jia HT
J Cell Biochem; 2009 Feb; 106(3):464-72. PubMed ID: 19115249
[TBL] [Abstract][Full Text] [Related]
26. Wild-type p53 transactivates the KILLER/DR5 gene through an intronic sequence-specific DNA-binding site.
Takimoto R; El-Deiry WS
Oncogene; 2000 Mar; 19(14):1735-43. PubMed ID: 10777207
[TBL] [Abstract][Full Text] [Related]
27. Hunchback sequence binding protein suppresses mouse TGF-beta3 promoter in vitro.
Yamazaki K; Crowe DL; Shuler CF
Biochem Biophys Res Commun; 2006 Aug; 346(3):802-9. PubMed ID: 16781676
[TBL] [Abstract][Full Text] [Related]
28. Ets transcription factors bind and transactivate the core promoter of the von Willebrand factor gene.
Schwachtgen JL; Janel N; Barek L; Duterque-Coquillaud M; Ghysdael J; Meyer D; Kerbiriou-Nabias D
Oncogene; 1997 Dec; 15(25):3091-102. PubMed ID: 9444957
[TBL] [Abstract][Full Text] [Related]
29. Co-regulation of B-Myb expression by E2F1 and EGF receptor.
Hanada N; Lo HW; Day CP; Pan Y; Nakajima Y; Hung MC
Mol Carcinog; 2006 Jan; 45(1):10-7. PubMed ID: 16299810
[TBL] [Abstract][Full Text] [Related]
30. [Study on cloning of hTERT promoter and its targeting transcriptional activities in telomerase-positive lung cancer cells].
Wang YP; Tang XJ; Chen XH; Che GW; Zhu DX; Sun ZL; Zhou QH
Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jul; 37(4):497-501. PubMed ID: 16909587
[TBL] [Abstract][Full Text] [Related]
31. Fibroblast growth factor-1 transcriptionally induces membrane type-1 matrix metalloproteinase expression in prostate carcinoma cell line.
Udayakumar TS; Nagle RB; Bowden GT
Prostate; 2004 Jan; 58(1):66-75. PubMed ID: 14673954
[TBL] [Abstract][Full Text] [Related]
32. Effects of the Ad5 upstream E1 region and gene products on heterologous promoters.
Hoffmann D; Jogler C; Wildner O
J Gene Med; 2005 Oct; 7(10):1356-66. PubMed ID: 15945123
[TBL] [Abstract][Full Text] [Related]
33. Cloning and analysis of rat osteoclast inhibitory lectin gene promoter.
Quan JX; Zheng F; Li XX; Hu LL; Sun ZY; Jiao YL; Wang BL
J Cell Biochem; 2009 Mar; 106(4):599-607. PubMed ID: 19127542
[TBL] [Abstract][Full Text] [Related]
34. [Construction of SIRT1 promoter expression vector and its activity analysis as well as influence of AML1-ETO on transcriptional regulation of SIRT1 gene].
Wang Q; Dou LP; Li YH; Wang LL; Zhou L; Li DD; Wang LJ; Yu L
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):12-8. PubMed ID: 25687038
[TBL] [Abstract][Full Text] [Related]
35. [Construction of a SV40 promoter specific artificial transcription factor].
Zhao XH; Zhu XD; Liu J; Rao XJ; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2003 Sep; 19(5):608-12. PubMed ID: 15969093
[TBL] [Abstract][Full Text] [Related]
36. [Construction of pGL3-SM22-SCAP (D443N) eukaryotic expression vector and its expression in CHO cells].
Wang Y; Hu J; Cui J; Huang A; Ruan X; Chen Y
Sheng Wu Gong Cheng Xue Bao; 2010 Jan; 26(1):114-20. PubMed ID: 20353101
[TBL] [Abstract][Full Text] [Related]
37. Transcriptional activation of the senescence regulator Lsh by E2F1.
Niu J; Chen T; Han L; Wang P; Li N; Tong T
Mech Ageing Dev; 2011 Apr; 132(4):180-6. PubMed ID: 21453717
[TBL] [Abstract][Full Text] [Related]
38. Regulation of the beta1,4-Galactosyltransferase I promoter by E2F1.
Wei Y; Zhou F; Ge Y; Chen H; Cui C; Liu D; Yang Z; Wu G; Shen J; Gu J; Jiang J
J Biochem; 2010 Sep; 148(3):263-71. PubMed ID: 20538716
[TBL] [Abstract][Full Text] [Related]
39. microRNA‑202 suppresses MYCN expression under the control of E2F1 in the neuroblastoma cell line LAN‑5.
Li YG; He JH; Yu L; Hang ZP; Li W; Shun WH; Huang GX
Mol Med Rep; 2014 Feb; 9(2):541-6. PubMed ID: 24337320
[TBL] [Abstract][Full Text] [Related]
40. [Differences in human and rat FSH receptors promote activity as a result of the transcriptional factors: E2F1, E2F4 and E2F5 overexpression].
Putowski L; Gasior W; Gogacz M; Gagała J; Jakowicki JA
Ginekol Pol; 2001 Dec; 72(12A):1560-6. PubMed ID: 11883315
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
